- Article
Exome Sequence Data of Eight SLC Transporters Reveal That SLC22A1 and SLC22A3 Variants Alter Metformin Pharmacokinetics and Glycemic Control
- Monserrat I. Morales-Rivera,
- Radamés Alemón-Medina,
- Angélica Martínez-Hernández,
- Cecilia Contreras-Cubas,
- Nelly F. Altamirano-Bustamante,
- Josefina Gómez-Garduño,
- Elvia C. Mendoza-Caamal,
- J. Orlando Nuñez-González,
- Raquel García-Álvarez and
- Lorena Orozco
- + 6 authors
Background: Type 2 diabetes (T2D) is one of the leading causes of mortality and is a public health challenge worldwide. Metformin is the first-choice treatment for T2D; its pharmacokinetics (PK) is facilitated by members of the solute carrier (SLC) s...